Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Haemonetics (HAE) Amortization - Intangibles (2020 - 2025)

Haemonetics has reported Amortization - Intangibles over the past 6 years, most recently at $10.9 million for Q4 2025.

  • For Q4 2025, Amortization - Intangibles fell 10.61% year-over-year to $10.9 million; the TTM value through Dec 2025 reached $44.8 million, down 5.46%, while the annual FY2025 figure was $48.3 million, 50.67% up from the prior year.
  • Amortization - Intangibles for Q4 2025 was $10.9 million at Haemonetics, down from $11.2 million in the prior quarter.
  • Over five years, Amortization - Intangibles peaked at $12.5 million in Q2 2024 and troughed at $6.9 million in Q4 2023.
  • A 5-year average of $10.1 million and a median of $11.1 million in 2025 define the central range for Amortization - Intangibles.
  • Biggest five-year swings in Amortization - Intangibles: tumbled 33.52% in 2022 and later soared 76.96% in 2024.
  • Year by year, Amortization - Intangibles stood at $11.4 million in 2021, then decreased by 29.14% to $8.1 million in 2022, then fell by 14.45% to $6.9 million in 2023, then soared by 76.96% to $12.2 million in 2024, then dropped by 10.61% to $10.9 million in 2025.
  • Business Quant data shows Amortization - Intangibles for HAE at $10.9 million in Q4 2025, $11.2 million in Q3 2025, and $11.4 million in Q2 2025.